Hepato-cellular carcinoma
Clinical trials for Hepato-cellular carcinoma explained in plain language.
Never miss a new study
Get alerted when new Hepato-cellular carcinoma trials appear
Sign up with your email to follow new studies for Hepato-cellular carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a common allergy pill keep liver cancer from returning?
Disease control Not yet recruitingThis trial investigates whether ebastine, a widely used allergy medication, can reduce the risk of liver cancer returning after surgery. The study enrolls people with a specific high-risk tumor feature called tumor budding. All participants will take ebastine daily for a year, an…
Matched conditions: HEPATO-CELLULAR CARCINOMA
Phase 4 • Sponsor: Second Affiliated Hospital of Xi'an Jiaotong University • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
3D MRI scan may predict liver cancer treatment success
Knowledge-focused Not yet recruitingThis study investigates whether a specialized MRI scan called three-dimensional magnetic resonance elastography (3D-MRE) can predict how well patients with initially unresectable liver cancer will respond to conversion therapy. The scan measures the stiffness and other physical p…
Matched conditions: HEPATO-CELLULAR CARCINOMA
Sponsor: Second Affiliated Hospital of Xi'an Jiaotong University • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
New scan could spot hidden cancer left behind after liver surgery
Knowledge-focused Not yet recruitingThis study investigates whether a special 3D MRI scan, called magnetic resonance elastography (3D-MRE), can detect microscopic tumor remnants at the surgical margin after liver cancer removal. Current methods only examine the removed tissue, not the remaining liver. Researchers w…
Matched conditions: HEPATO-CELLULAR CARCINOMA
Sponsor: Second Affiliated Hospital of Xi'an Jiaotong University • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC